Libertas 7 SA
MAD:LIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Libertas 7 SA
MAD:LIB
|
ES |
|
F
|
Fine Metal Technologies PCL
SET:FMT
|
TH |
|
Supercom Ltd
NASDAQ:SPCB
|
IL |
|
Stoneweg Europe Stapled Trust
SGX:SET
|
SG |
|
B
|
Basic Net SpA
F:BCJ
|
IT |
|
Arbutus Biopharma Corp
NASDAQ:ABUS
|
US |
|
T
|
Tuga Innovations Inc
F:DQ5
|
CA |
|
S
|
Schneider Electric SE
F:SND
|
FR |
|
Fresenius Medical Care AG
XMUN:FME
|
DE |
|
CES Synergies Inc
OTC:CESX
|
US |
|
Commercial Syn Bags Ltd
NSE:COMSYN
|
IN |
|
Plus500 Ltd
LSE:PLUS
|
IL |
|
McCoy Global Inc
F:773
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LIB's stock price target?
Not Available
LIB does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Libertas 7 SA?
Projected CAGR
32%
Over the last 13 years, the compound annual growth rate for Revenue has been -6%. The projected CAGR for the next 3 years is 32%.
What is the Gross Profit forecast for Libertas 7 SA?
Projected CAGR
21%
The compound annual growth rate for Gross Profit over the next 3 years is 21%.
What is the Operating Income forecast for Libertas 7 SA?
Projected CAGR
27%
The compound annual growth rate for Operating Income over the next 3 years is 27%.
What is the Pre-Tax Income forecast for Libertas 7 SA?
Projected CAGR
21%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 21%.
What is the Net Income forecast for Libertas 7 SA?
Projected CAGR
22%
The compound annual growth rate for Net Income over the next 3 years is 22%.
